Modulate Bio
Skip to content
Modulate Bio

Student i-lab

Modulate Bio

Developing therapies to treat neurological disorders, including Essential Tremor, epilepsy, and anxiety.


Andrew Thomson

Harvard Business School

About Modulate Bio


2024 Spring


Harvard Business School


Email, Website, LinkedIn

Modulate Bio is making medicines to help millions of patients struggling with debilitating neurological disorders. Our fine-tuned therapies bind to specific brain receptors and restore healthy function, without over-activation. By avoiding this over-activation, we provide safe, effective treatments patients can take long-term. Our team is now identifying a lead drug to bring to human clinical trials in Essential Tremor, followed closely by epilepsy and anxiety. We are excited to advance the first novel treatment to help Essential Tremor patients, families, and caretakers in over half a century.

Join Us

Summer 2024 membership is now open – we cannot wait to be a part of your entrepreneurial journey.

Students at a networking event